PRKAA1 and Myocardial fibrosis: In the heart, it is known that this enzyme also exhibits non-metabolic effects like regulation of myocardial fibrosis and inhibition of cytosolic reactive oxygen species (ROS) production by NADPH oxidase [13–16]; this has to be considered when deciphering the part played by AMPK in cardiac physiology and pathophysiology.